Your browser doesn't support javascript.
loading
Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth.
Keller, Magdalena; Rohlf, Katharina; Glotzbach, Annika; Leonhardt, Gregor; Lüke, Simon; Derksen, Katharina; Demirci, Özlem; Göçener, Defne; AlWahsh, Mohammad; Lambert, Jörg; Lindskog, Cecilia; Schmidt, Marcus; Brenner, Walburgis; Baumann, Matthias; Zent, Eldar; Zischinsky, Mia-Lisa; Hellwig, Birte; Madjar, Katrin; Rahnenführer, Jörg; Overbeck, Nina; Reinders, Jörg; Cadenas, Cristina; Hengstler, Jan G; Edlund, Karolina; Marchan, Rosemarie.
Affiliation
  • Keller M; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
  • Rohlf K; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
  • Glotzbach A; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
  • Leonhardt G; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
  • Lüke S; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
  • Derksen K; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
  • Demirci Ö; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
  • Göçener D; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
  • AlWahsh M; Leibniz Institut Für Analytische Wissenschaften - ISAS E.V, Dortmund, Germany.
  • Lambert J; Institute of Pathology and Medical Research Center (ZMF), University Medical Center Mannheim, Heidelberg University, Mannheim, Germany.
  • Lindskog C; Department of Pharmacy, AlZaytoonah University of Jordan, Amman, Jordan.
  • Schmidt M; Leibniz Institut Für Analytische Wissenschaften - ISAS E.V, Dortmund, Germany.
  • Brenner W; Department of Immunology Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Baumann M; Department of Obstetrics and Gynecology, University Medical Center Mainz, Mainz, Germany.
  • Zent E; Department of Obstetrics and Gynecology, University Medical Center Mainz, Mainz, Germany.
  • Zischinsky ML; Pharmacology Department, Lead Discovery Center, Dortmund, Germany.
  • Hellwig B; Pharmacology Department, Lead Discovery Center, Dortmund, Germany.
  • Madjar K; Pharmacology Department, Lead Discovery Center, Dortmund, Germany.
  • Rahnenführer J; Department of Statistics, TU Dortmund University, Dortmund, Germany.
  • Overbeck N; Department of Statistics, TU Dortmund University, Dortmund, Germany.
  • Reinders J; Department of Statistics, TU Dortmund University, Dortmund, Germany.
  • Cadenas C; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
  • Hengstler JG; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
  • Edlund K; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
  • Marchan R; Leibniz Research Centre for Working Environment and Human Factors at the TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.
J Exp Clin Cancer Res ; 42(1): 25, 2023 Jan 20.
Article in En | MEDLINE | ID: mdl-36670508

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: J Exp Clin Cancer Res Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: J Exp Clin Cancer Res Year: 2023 Document type: Article Affiliation country: